Arcellx, Inc. (ACLX)
NASDAQ: ACLX · Real-Time Price · USD
115.00
-0.05 (-0.04%)
At close: Apr 20, 2026, 4:00 PM EDT
115.04
+0.04 (0.03%)
Pre-market: Apr 21, 2026, 8:46 AM EDT
Arcellx Employees
Arcellx had 209 employees as of December 31, 2025. The number of employees increased by 46 or 28.22% compared to the previous year.
Employees
209
Change (1Y)
46
Growth (1Y)
28.22%
Revenue / Employee
$106,632
Profits / Employee
-$1,095,378
Market Cap
6.75B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 209 | 46 | 28.22% |
| Dec 31, 2024 | 163 | 33 | 25.38% |
| Dec 31, 2023 | 130 | 32 | 32.65% |
| Dec 31, 2022 | 98 | 20 | 25.64% |
| Dec 31, 2021 | 78 | 47 | 151.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 991 |
| Rhythm Pharmaceuticals | 414 |
| Apogee Therapeutics | 261 |
| Cogent Biosciences | 258 |
| Kymera Therapeutics | 238 |
| CG Oncology | 142 |
| Protagonist Therapeutics | 132 |
| Centessa Pharmaceuticals | 118 |
ACLX News
- 4 weeks ago - Halper Sadeh LLC is Investigating Whether KW, ACLX are Obtaining Fair Deals for their Shareholders - GlobeNewsWire
- 4 weeks ago - Top 2 Health Care Stocks That May Fall Off A Cliff This Month - Benzinga
- 6 weeks ago - Top 2 Health Care Stocks That May Crash This Quarter - Benzinga
- 2 months ago - Here's Why Shares of Arcellx Are Up Almost 80% Today - Investopedia
- 2 months ago - Why is Arcellx stock up 80% today? Gilead's $7.8B answer - Invezz
- 2 months ago - Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion - Reuters
- 2 months ago - Gilead Sciences to Buy Arcellx in Deal Valued at $7.8 Billion - WSJ
- 2 months ago - Gilead to acquire Arcellx for $7.8 billion - Reuters